Literature DB >> 20521062

Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy.

Hani A Al Shobaili1, Hossam O Hamed, Ahmad Al Robaee, Abdullateef A Alzolibani, Ahmad F Amin, Salah R Ahmad.   

Abstract

PURPOSES: To determine the incidence, obstetrical, and fetal complication rates of intrahepatic cholestasis of pregnancy (ICP) in patients managed expectantly to 40-weeks gestation.
METHODS: In a prospective cohort study conducted between February 2008 and January 2010, a total of 21,960 pregnant women in Qassim Region of Saudi Arabia were screened for ICP using specific criteria for diagnosis. The course of pregnancy was monitored to 40-weeks gestation or spontaneous onset of labor, whichever comes first. The measured outcomes were compared with a cross-matched group of healthy pregnant women. Continuous variables were analyzed with t test, while χ(2) test was used for comparing percentages.
RESULTS: The incidence of ICP was 0.35% (76/21,960). There was no significant difference between groups in gestational age at delivery, preterm labor, intrauterine fetal death, cesarean section, or respiratory distress syndrome. There was significantly higher intrapartum non-reassuring fetal heart rate patterns and meconium-stained amniotic fluid in ICP group (P < 0.01 and <0.0001, respectively).
CONCLUSIONS: The incidence of ICP in this region is low compared to worldwide range. Expectant management to 40-weeks gestation is associated with obstetrical and fetal outcomes comparable to normal pregnancy; however, intrapartum fetal asphyxia is more likely.

Entities:  

Mesh:

Year:  2010        PMID: 20521062     DOI: 10.1007/s00404-010-1506-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Intrahepatic cholestasis of pregnancy: biochemical predictors of adverse perinatal outcomes.

Authors:  Hui Chen; Yuan Zhou; Dong-Rui Deng; Hai-Yan Hao; Jing Dang; Jing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.

Authors:  Caroline Ovadia; Paul T Seed; Alexandros Sklavounos; Victoria Geenes; Chiara Di Ilio; Jenny Chambers; Katherine Kohari; Yannick Bacq; Nuray Bozkurt; Romana Brun-Furrer; Laura Bull; Maria C Estiú; Monika Grymowicz; Berrin Gunaydin; William M Hague; Christian Haslinger; Yayi Hu; Tetsuya Kawakita; Ayse G Kebapcilar; Levent Kebapcilar; Jūratė Kondrackienė; Maria P H Koster; Aneta Kowalska-Kańka; Limas Kupčinskas; Richard H Lee; Anna Locatelli; Rocio I R Macias; Hanns-Ulrich Marschall; Martijn A Oudijk; Yael Raz; Eli Rimon; Dan Shan; Yong Shao; Rachel Tribe; Valeria Tripodi; Cigdem Yayla Abide; Ilter Yenidede; Jim G Thornton; Lucy C Chappell; Catherine Williamson
Journal:  Lancet       Date:  2019-02-14       Impact factor: 202.731

Review 3.  Stillbirth and associated perinatal outcomes in obstetric cholestasis: a systematic review and meta-analysis of observational studies.

Authors:  Manoj Mohan; Antoniou Antonios; Justin Konje; Stephen Lindow; Mohamed Ahmed Syed; Anthony Akobeng
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-02

4.  Serum hepatic biomarkers in women with obstetric cholestasis and a concurrent SARS-CoV-2 infection.

Authors:  Francesco D'Ambrosi; Matteo Di Maso; Anna Viscardi; Manuela W Ossola; Chiara M Soldavini; Giulia E Cetera; Roberta Erra; Enrico Ferrazzi
Journal:  J Obstet Gynaecol Res       Date:  2022-08-01       Impact factor: 1.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.